Key regions: France, Canada, United States, Australia, Europe
The Prescription Drugs (Pharmacies) market in Australia & Oceania is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.
Customer preferences: Customers in Australia & Oceania have a strong preference for prescription drugs from pharmacies due to the convenience and accessibility they offer. Pharmacies provide a one-stop solution for customers to obtain their prescribed medications, eliminating the need for additional visits to healthcare facilities. Additionally, pharmacies often offer a wide range of over-the-counter medications and health products, making them a convenient choice for customers seeking multiple healthcare solutions in one place.
Trends in the market: One of the key trends in the Prescription Drugs (Pharmacies) market in Australia & Oceania is the increasing demand for personalized healthcare services. Pharmacies are evolving to provide more comprehensive services, such as medication therapy management, medication counseling, and health screenings. This trend is driven by the growing awareness among customers about the importance of proactive healthcare management and the desire for personalized treatment plans. Another trend in the market is the integration of technology in pharmacy operations. Many pharmacies in Australia & Oceania are adopting digital solutions to streamline processes, improve inventory management, and enhance customer experience. This includes online prescription ordering and delivery services, electronic health records, and mobile applications for medication reminders and dosage tracking.
Local special circumstances: Australia & Oceania is known for its vast geographical area and remote communities. This presents unique challenges in terms of healthcare accessibility, particularly in rural and remote areas. Pharmacies play a crucial role in bridging this gap by providing essential healthcare services, including prescription drugs, to these underserved communities. The presence of pharmacies in these areas ensures that residents have access to necessary medications without having to travel long distances.
Underlying macroeconomic factors: The growing aging population in Australia & Oceania is a significant macroeconomic factor contributing to the development of the Prescription Drugs (Pharmacies) market. As the population ages, the demand for prescription medications increases, driving the growth of the pharmacy industry. Additionally, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, further fuels the demand for prescription drugs and pharmacy services. Furthermore, government policies and healthcare reforms play a crucial role in shaping the Prescription Drugs (Pharmacies) market in Australia & Oceania. Government initiatives to improve healthcare accessibility and affordability, such as the provision of subsidized medications and the expansion of telehealth services, have a positive impact on the pharmacy industry. These policies encourage customers to seek prescription drugs from pharmacies, further driving market growth. In conclusion, the Prescription Drugs (Pharmacies) market in Australia & Oceania is developing due to customer preferences for convenience and accessibility, trends in personalized healthcare services and technology integration, local special circumstances in remote areas, and underlying macroeconomic factors such as the aging population and government policies. These factors contribute to the steady growth and expansion of the pharmacy industry in the region.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
